Home Page
Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Donate Now
Access Resources

MJFF Publications
2861 - 2870 of 9145 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Association of Early Weight Change With Cognitive Decline in Patients With Parkinson Disease
    2022
    Summary Details
    RESTRICTED
    Title: Association of Early Weight Change With Cognitive Decline in Patients With Parkinson Disease
    Author(s): Ryul Kim, Seo Hee Choi, Kyeongho Byun, Nyeonju Kang, Young Ju Suh, Jin‐Sun Jun, Beomseok Jeon
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 100
    Issue #: 2
    Start Page: e232
    End Page: e241
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201404
    Citation Count: 12
  • Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSI
    2022
    Summary Details
    RESTRICTED
    Title: Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSI
    Author(s): Jannik Prasuhn, Martin Göttlich, Britt Ebeling, Sofia Kourou, Friederike Gerkan, Christina Bodemann, Sinja S. Großer, Katharina Reuther, Henrike Hanßen, Norbert Brüggemann
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 24
    Start Page: e2683
    End Page: e2692
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201288
    Citation Count: 16
  • Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)
    2022
    Summary Details
    OPEN
    Title: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)
    Author(s): Jeffrey C. Allen, Eduardo Nobile‐Orazio, Stojan Perić, Hans Katzberg, Stéphanie Cadour, Inge Van de Walle, Iris van Hoomissen, Bert Jacquemyn, Olivier Van de Steen, W. Ludo van der Pol
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdf
    Citation Count: 4
  • 2022 Emerging Science Abstracts
    2022
    Summary Details
    RESTRICTED
    Title: 2022 Emerging Science Abstracts
    Author(s):
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 3
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200917
    Citation Count: 1
  • Progressive Supranuclear Palsy Syndrome Associated With a Novel Tauopathy
    2022
    Summary Details
    RESTRICTED
    Title: Progressive Supranuclear Palsy Syndrome Associated With a Novel Tauopathy
    Author(s): Shelley L. Forrest, Maria Carmela Tartaglia, Ain Kim, Paula Alcaide‐Leon, Ekaterina Rogaeva, Anthony E. Lang, Gábor G. Kovács
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 24
    Start Page: 1094
    End Page: 1098
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201485
    Citation Count: 16
  • Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls
    2022
    Summary Details
    OPEN
    Title: Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls
    Author(s): Tyler L. Borko, Britney Barrera, Christopher Mizenko, Aurélie Ledreux, Ryan Kammeyer, Alanna Ritchie, Sean Selva, Stefan Sillau, Eric Engebretson, Rebecca Seale, Brooke Valdez, Jeffrey L. Bennett, Timothy L. Vollmer, Kavita Nair, Amanda L. Piquet
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903096.36040.1d
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S8.full.pdf
    Citation Count: 0
  • Interfacility Transfers for Seizure-Related Emergencies in the United States
    2022
    Summary Details
    OPEN
    Title: Interfacility Transfers for Seizure-Related Emergencies in the United States
    Author(s): Emily K. Acton, Leah J. Blank, Allison W. Willis, Ali G. Hamedani
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 24
    Start Page: e2718
    End Page: e2727
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201319
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9757868
    Citation Count: 9
  • The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis
    2022
    Summary Details
    OPEN
    Title: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis
    Author(s): Ka‐Ho Wong, Gregory S. Day, Maarten J. Titulaer, James C. Torner, Merit Cudkowicz, Christopher S. Coffey, Codrin Lungu, Eric C. Klawiter, J. Singleton, Dana Mitchell, Janel Fedler, Dixie Ecklund, David Klements, Michele Costigan, Stacey Clardy
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdf
    Citation Count: 4
  • Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant
    2022
    Summary Details
    OPEN
    Title: Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant
    Author(s): Rachel Saunders‐Pullman, Roberto Angel Ortega, Cuiling Wang, Deborah Raymond, Sonya Elango, Katherine Leaver, Nikita Urval, Viktoriya Katsnelson, Rachel S. Gerber, Matthew Swan, Vicki Shanker, Roy N. Alcalay, Anat Mirelman, Michael C. Brumm, Helen Mejia‐Santana, Christopher S. Coffey, Kenneth Marek, Laurie J. Ozelius, Nir Giladi, Karen Marder, Susan Bressman
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 8
    Start Page: e814
    End Page: e823
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200737
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9484727
    Citation Count: 10
  • Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers
    2022
    Summary Details
    OPEN
    Title: Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers
    Author(s): Amgad Droby, Moran Artzi, Hedva Lerman, R. Matthew Hutchison, Dafna Ben Bashat, Nurit Omer, Tanya Gurevich, Avi Orr‐Urtreger, Batsheva Cohen, Jesse M. Cedarbaum, Einat Even Sapir, Nir Giladi, Anat Mirelman, Avner Thaler
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Vol: 8
    Issue #: 1
    Start Page: 20
    End Page: 20
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00285-z
    Best OA location URL: https://www.nature.com/articles/s41531-022-00285-z.pdf
    Citation Count: 11

We are charting the path to a future free from Parkinson’s. Your support will get us there.

Give Today About Our Campaign
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.